In brief, OPTN mutations primarily cause ALS by under expressing and causing complete loss of function of the expression product, which could impact ALS onset and progression via pathways including mitophagy, protein aggregation, neuroinflammation, vesicular transport, axonal degeneration, and oxidative stress (Figure 2). The gene discussed is OPTN; the disease is amyotrophic lateral sclerosis.